One other employee is undergoing treatment in a hospital after the incident that occurred on Monday evening, Laurus said.
The company, which specializes in anti-retroviral, hepatitis C and oncology drugs, said it has launched an investigation, without giving any other specifics about the incident.
Laurus said its other manufacturing blocks were running normally and that it did not expect any material impact on its operations.
It employs over 5,700 people at more than eight facilities including in the Indian cities of Hyderabad and Visakhapatnam, according to a July filing.
Laurus's shares fell as much as 2.4% in early trading on Tuesday, before recovering to trade down 0.5%. They had already declined about 29% so far this year.
(Reporting by Praveen Paramasivam in Chennai; Editing by Janane Venkatraman)
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in